Early posttransplant erythrocytosis in renal allograft recipients. 2010

Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
Dept. of Nephrology, Institute of Medical Science, Banaras Hindu University, Varanasi 221005, India.

Posttransplant erythrocytosis (PTE) is defined as a persistently elevated hematocrit to a level greater than 51% after renal transplantation. It usually develops 8 to 24 months after transplantation. We report occurrence of PTE in two male renal allograft recipients within first 8 months of transplantation.

UI MeSH Term Description Entries
D008297 Male Males
D011086 Polycythemia An increase in the total red cell mass of the blood. (Dorland, 27th ed) Erythrocytosis,Erythrocytoses,Polycythemias
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
May 1998, Transplantation proceedings,
Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
December 1992, Transplantation proceedings,
Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
January 2001, Transplantation proceedings,
Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
February 1993, Transplantation proceedings,
Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
May 1998, Transplantation proceedings,
Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
June 2005, Transplantation proceedings,
Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
December 2009, Artificial organs,
Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
December 2006, Transplantation proceedings,
Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
February 1989, Transplantation,
Jai Prakash, and Shivendra Singh, and Sanjeev Kumar Behur, and Biplab Ghosh, and L K Sharatchandra, and U S Dwivedi
January 1992, Transplant international : official journal of the European Society for Organ Transplantation,
Copied contents to your clipboard!